Medications for Influenza Vaccines

4 results

  • flublok trivalent northern hemisphere

    (INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/MASSACHUSETTS/18/2022 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN)
    Sanofi Pasteur Inc.
    Flublok is a vaccine indicated for active immunization against influenza A virus subtypes and influenza type B virus. It is approved for use in individuals aged 18 years and older to prevent influenza-related diseases.

  • fluzone hd quadrivalent southern hemisphere

    (INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), andINFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED))
    Sanofi Pasteur Inc.
    Fluzone® High-Dose Quadrivalent Southern Hemisphere is a vaccine for active immunization against influenza A and B viruses, specifically indicated for individuals 65 years and older.

  • fluzone hd tiv sh 2025

    (INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED))
    Sanofi Pasteur Inc.
    Fluzone® High-Dose Southern Hemisphere is a vaccine for active immunization against influenza A and B viruses. It is specifically approved for individuals 65 years and older to help prevent influenza-related disease.

  • fluzone trivalent southern hemisphere

    (INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED))
    Sanofi Pasteur Inc.
    Fluzone® Southern Hemisphere is a vaccine for active immunization against influenza A subtype viruses and type B virus. It is approved for individuals 6 months and older.